Session

Joint Session of the European Association of Urology (EAU) and the Korean Urological Association (KUA) - `Upper tract urothelial cancer and prostate cancer: Is there a difference in the approach in Korea and Europe?'

Urology beyond Europe

  • Location:
    Room London (Hall B2, level 0)
  • Chairs:
     A. Stenzl, Tübingen (DE)
     G.T. Sung, Busan (KR)
  • Aims and objectives of this session

    Members of the Korean Urological Association and the European Association of Urology will give an overview of new approaches to two important topics. The aim of this session is to show both the latest developments in upper tract urothelial cancer and biochemically recurrent prostate cancer, as well as different clinical applications of new developments in Korea and Europe.

Welcome and introduction
 
 A. Stenzl, Tübingen (DE)
 
 M-S. Choo, Seoul (KR)
Urothelial cancer of the upper urinary tract
 
Moderators:
 S.J. Kim, Suwon (KR)
 
 
 S. Shariat, Vienna (AT)
Diagnosis and follow-up of Upper Tract Urothelial Cancer (UTUC): Korean approach
 J.S. Cho, Ahnyang (KR)
Discussion
Diagnosis and follow-up of Upper Tract Urothelial Cancer (UTUC): European approach
 S. Shariat, Vienna (AT)
Discussion
Organ-sparing treatment of Upper Tract Urothelial Cancer (UTUC): Korean approach
 B.C. Jeong, Seoul (KR)
Discussion
Organ-sparing treatment of Upper Tract Urothelial Cancer (UTUC): European approach
 J.J.M.C.H. De La Rosette, Amsterdam (NL)
Discussion
State-of-the-art lecture Systemic treatment of metastatic urothelial cancer: Upper tract versus bladder
 M. De Santis, Coventry (GB)
Prostate cancer: Biochemical recurrence after radical prostatectomy
 
Moderators:
 A. Briganti, Milan (IT)
 
 
 C-S. Kim, Seoul (KR)
Role of blood tests and imaging studies in the diagnosis of biochemical recurrence: Korean approach
 S.J. Yun, Cheongju - Chungbuk (KR)
Discussion
Role of blood tests and imaging studies in the diagnosis of biochemical recurrence: European approach
 P. Albers, Düsseldorf (DE)
Discussion
Optimal management for biochemical recurrence: Korean approach
 W.K. Han, Seoul (KR)
Discussion
Optimal Managements for biochemical recurrence: European approach
 A. Briganti, Milan (IT)
Discussion
Joint Korean – European case discussion
 
 P. Albers, Düsseldorf (DE)
 
 A. Briganti, Milan (IT)
 
 J.H. Ku, Seoul (KR)
 
 S.I. Seo, Seoul (KR)
Case 1
 J.Y. Joung, Goyang (KR)
Case 2
 A. Stenzl, Tübingen (DE)
Conclusion
 
 A. Stenzl, Tübingen (DE)
 
 G.T. Sung, Busan (KR)